Medivizor

Company Overview

Snapshot

Founded in August 2012 by Tal Givoly and Dr. Steven Kaplan, Medivizor operates with 1–10 employees. The company has secured funding across one disclosed round. In August 2020, Medivizor announced a collaboration agreement with My Personal Therapeutics.

Business overview

Medivizor develops a patented, award-winning platform that provides personalized, trusted, and current medical science information to patients, caregivers, and doctors. The company's core technology leverages artificial intelligence to educate, engage, empower, and support patients living with serious or chronic illnesses. Medivizor serves healthcare providers, patient advocacy organizations, and the biopharmaceutical industry, enabling patient recruitment for clinical trials, direct-to-consumer marketing, and insights. It operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Patient Engagement.

Strategic signal

In August 2020, Medivizor signed a multi-year agreement with MedEvoke to streamline clinical trial recruitment efforts for pharmaceutical, biotechnology, and medical device clients. This partnership signals Medivizor's strategic expansion into supporting the biopharmaceutical industry, validating its platform's utility beyond direct patient engagement to critical industry functions like clinical trial enrollment. For investors, this indicates a diversified revenue stream and a strengthened position within the broader healthcare ecosystem.

Company Intelligence Q&A

What is Medivizor's primary focus?

Medivizor focuses on supporting patients living with serious or chronic illnesses by providing access to current, trusted, and personally relevant medical science information through its patented platform.

When was Medivizor founded and by whom?

Medivizor was founded in August 2012 by Tal Givoly and Dr. Steven Kaplan.

What significant partnership did Medivizor announce in August 2020?

In August 2020, Medivizor signed a multi-year agreement with MedEvoke to streamline clinical trial recruitment efforts for pharmaceutical, biotechnology, and medical device clients.

What collaboration agreement did Medivizor enter into in August 2020?

In August 2020, Medivizor announced a collaboration agreement with My Personal Therapeutics.

What technology does Medivizor utilize in its platform?

Medivizor utilizes artificial intelligence to provide personalized health information and support patient engagement.